Abstract: The present invention relates to a mitochondrion containing a compound having the anticancer efficacy and uses thereof. It was confirmed that the mitochondrion efficiently deliver the compound to the tumor, and the anticancer effect of the mitochondrion containing the compound was confirmed. In particular, when an antibody or a fragment thereof that specifically binds to a tumor is bound to the surface of mitochondrion, the compound may be delivered specifically to the tumor. Therefore, the mitochondrion containing the compound according to the present invention may be effectively used for the treatment of cancer because the side effects of the compound are few.

Abstract: Interface devices and systems that include interface devices are disclosed. In some implementations, a device includes a transceiver configured to transmit and receive data, a lane margining controller in communication with the transceiver and configured to control the transceiver to transmit, through a margin command, to an external device, a request for requesting a state of an elastic buffer of the external device, and control the transceiver to receive the state of the elastic buffer of from the external device, and a port setting controller adjust a clock frequency range of a spread spectrum clocking scheme based on the state of the elastic buffer.

Abstract: Provided are a method for obtaining active mitochondria by freezing platelets and a use of isolated mitochondria, and more specifically, to a method for obtaining mitochondria by thawing platelets after freezing the same and a pharmaceutical composition containing the mitochondria obtained by the method as an active ingredient. The present disclosure, by providing a method for obtaining mitochondria by thawing platelets in a frozen state in a preservation solution, not only enables to obtain mitochondria in which the activity is stably maintained, but also enables to provide a commercial value for donor platelets that are discarded after refrigeration for a short period of time. Additionally, the pharmaceutical composition containing platelet-derived mitochondria obtained by the above method may be effectively used to treat various diseases caused by mitochondrial dysfunction.

Abstract: A foldable seat apparatus for a multi-purpose vehicle is provided. The apparatus includes a seat unit composed of a seat cushion, and a seatback rotatably coupled to the seat cushion, and configured to rotate the seatback and formed to make a horizontal state with the seat cushion according to an operation of an operation lever, a headrest unit mounted on the seatback, and provided to be separable, a mounting guide unit fixed and coupled to the seat cushion; and a pillow mounting unit positioned to be latched to the mounting guide unit to be stored in the seat cushion, drawn out to the outside of the seat cushion by selectively being latch-released from the mounting guide unit in the horizontal state, and equipped with the headrest unit to guide the headrest unit to be switched to a set pillow mode.

Abstract: A device for providing a fatigue-reducing position of a vehicle seat is provided. A first latch unit is mounted on a rear seat cushion such that a first striker mounted on a front seatback is fastened thereto in a lockable manner. A second latch unit is mounted on a rear surface portion of a rear seatback. A sliding-locking unit is mounted on a package panel disposed behind a rear seat in a height adjustable manner. A second striker is provided on a front end of the sliding-locking unit to be fastened to the second latch unit in a lockable manner. A seat in a second or third row in the cabin of a vehicle is detachable from the original position to be fixedly placed like a hammock between a front seat and a package panel to provide a fatigue-reducing position in which an occupant comfortably rests.

Abstract: Provided is a composition for injection containing isolated mitochondria. More specifically, provided is a liquid composition for injection containing glycine, saccharide, buffer, and mitochondria, and a pharmaceutical composition comprising the liquid composition for injection as an active ingredient. The liquid composition for injection according to the present disclosure is capable of securing the safety of a mitochondrial therapeutic and maintaining the activity of mitochondria, by enhancing the stability of mitochondria for prevention or treatment of mitochondria-related diseases and preventing and inhibiting formation of blood clots in the blood of a subject who is administered with the same.

Abstract: A pixel includes a first transistor connected between a first power line and a first node, and including a gate electrode connected to a second node, a second transistor connected between a data line and the second node, and including a gate electrode connected to a scan line, a third transistor connected between a first sensing line and the first node, and including a gate electrode connected to a first control line, a fourth transistor connected between a second sensing line and a third node, and including gate electrode connected to a second control line, a first sub light emitting unit including light emitting elements connected in parallel in a forward direction between the first node and the third node, and a second sub light emitting unit including light emitting elements connected in parallel in the forward direction between the third node and a second power line.

Abstract: A method of operating an interface device including a first elastic buffer is provided. The method of operating the interface device includes initializing one or more parameters associated with clock signals for a data transmission or reception of the interface device, checking whether the interface device is in a predetermined mode for adjusting the one or more parameters, adjusting, upon determination that the interface device is in the predetermined mode, the one or more parameters associated with the clock signals of the interface device based on how much of the first buffer or the second buffer is filled with data, and performing the data transmission or reception based on the adjusted one or more parameters associated with the clock signals.

Abstract: A display device includes a substrate, a first data fan-out line disposed on the substrate, a first data line disposed on the first data fan-out line and comprising a repair area overlapping the first data fan-out line, a color filter disposed on the first data line and overlapping the repair area, and a connection electrode disposed in the repair area and being in direct contact with the first data fan-out line and the first data line.

Abstract: A process proximity correction method is performed by a process proximity correction computing device which performs a process proximity correction (PPC) through at least one of a plurality of processors. The process proximity correction method includes: converting a target layout including a plurality of patterns into an image, zooming-in or zooming-out the image at a plurality of magnifications to generate a plurality of input channels, receiving the plurality of input channels and performing machine learning to predict an after-cleaning image (ACI), comparing the predicted after-cleaning image with a target value to generate an after-cleaning image error, and adjusting the target layout on the basis of the after-cleaning image error.

Abstract: The present invention relates to a method for manufacturing a paper buffer tray for packaging and a buffer tray manufactured thereby, wherein a plurality of papers are laminated and processed such that some papers are cut in a length direction, wrinkles or the like are formed in the other papers, and press-molding is performed using a mold, thereby providing an eco-friendly buffer tray and overcoming a disadvantage in that it is difficult to mold a buffer tray by using an existing paper. The method for manufacturing the paper buffer tray for packaging includes: a raw material preparing step of preparing a raw material for manufacturing a buffer tray in which a plurality of papers are laminated; a molding preparing step of preparing at least one mold corresponding to a shape and size of a product to be packaged; and a molding step of press-molding the raw material by using the at least one mold.

Abstract: The present invention relates to a pharmaceutical composition comprising an immunoglobulin Fc region and an IL-7 fusion protein. Specifically, when a fusion protein comprising the immunoglobulin Fc region and IL-7 is administered to an affected area, a strong immune response is induced in the body and thus allows human papillomavirus-caused diseases to be prevented or treated.

Abstract: A display device, includes: a display panel including a pixel electrically coupled to a gate line and a data line; a gate driver configured to provide a gate signal to the gate line; and a data driver configured to provide a data signal to the data line, wherein the gate driver is configured to sequentially provide a first gate signal and a second gate signal to the gate line during a first frame period, wherein the data driver is configured to provide a first data signal to the data line in response to the first gate signal, and to provide a second data signal to the data line in response to the second gate signal, and wherein the second data signal is different from the first data signal and varies dependent on the first data signal.

Abstract: Disclosed is a semiconductor integrated circuit fabricating method of a semiconductor fabricating device which includes a processor executing a defect detection module includes receiving, at the defect detection module, a first capture image of the semiconductor integrated circuit and a first layout image, generating, at the defect detection module, a second layout image from the first capture image, generating, at the defect detection module, a contour image from the first capture image and the second layout image, detecting, at the defect detection module, a defect of the semiconductor integrated circuit based on the first layout image and the contour image, analyzing, at the semiconductor fabricating device, a correlation between a kind of the defect and process variations of the semiconductor integrated circuit, and changing, at the semiconductor fabricating device, at least one process variation having a correlation with the defect from among the process variations.

Abstract: A display device includes: pixels, each of the pixels including at least one light emitting element and a first transistor configured to supply a driving current to the at least one light emitting element; a sensing unit configured to sense a driving current of the first transistor, which corresponds to a data voltage applied to one pixel from among the pixels, the sensing unit being configured to detect a luminance of the light emitting element, which corresponds to the driving current; a gamma calculator configured to receive the driving current and the luminance of the light emitting element from the sensing unit, to calculate a gamma changed based on the driving current and the luminance of the light emitting element, and to provide, to a memory, the gamma changed based on the driving current and the luminance of the light emitting element.

Abstract: A method, a system, and a computer-readable recording medium implement a fast-switching mode between channels in a multi-live transmission environment. A composite image in which images of multiple channels are synthesized into one image in a live transmission environment is received as one stream to configure a multi-view composed of the images of the multi-channels and, as an image of a specific channel is selected in the multi-view, the original image of the specific channel is received and the multi-view may be switched to a full-view of the image of the specific channel.

Abstract: Provided is a Bifidobacterium animalis subsp. Lactis GFC-B09 strain and a cosmetic composition containing the same. The Bifidobacterium animalis subsp. Lactis GFC-B09 strain (Accession number: KCCM12263P) or a culture solution thereof has the ability to increase the amount of S. epidermidis, to degrade histamine, to inhibit allergies, to repair DNA, and to increase wrinkle resistance, skin whiteness, skin density, and skin elasticity, and thus can exhibit excellent effects as a cosmetic composition when contained as an active ingredient in a cosmetic base.

Abstract: A display device includes a substrate including a display area and a non-display area disposed around the display area; a fan-out unit disposed in the non-display area and including a first pad unit and a first fan-out line electrically connected to the first pad unit; a first signal line disposed on a different layer from the first fan-out line and including a first area overlapping the first fan-out line; a first switching element disposed on the display area and electrically connected to the first signal line and a first pixel electrode; and a color filter overlapping the first area.

Abstract: The present invention relates to a system and method for separating and recovering hydrogen from coke oven gas (COG) in steel industry, particularly a system and method for separating and recovering hydrogen at a concentration of 99.9% by volume or more from coke oven gas (COG) in steel industry with a recovery rate of 95% or more.

Abstract: An artificial intelligence-based control method is disclosed. In an artificial intelligence-based control method according to an exemplary embodiment of the present disclosure, when a user approaches within a set sensing range of a device, the device may capture a user image and predict whether the user has an intent to use the device by using motion features included in the captured image. An AI control method of the present disclosure may be associated with an artificial intelligent module, an unmanned aerial vehicle (UAV), a robot, an augmented reality (AR) device, a virtual reality (VR) device, a 5G service-related device, etc.